ZYMEWORKS INC. Shareholders' Equity
ZYMEWORKS INC. (ZYME) had Shareholders' Equity of $80.37 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-06
- 2026-06-30: Stockholders' Equity Attributable to Parent $80.37M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $163.59M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $268.50M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $320.06M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $80.37M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $163.59M 10-Q · filed 2026-08-06 |
| 2025-12-31 | $268.50M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $320.06M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $334.51M 10-Q · filed 2026-08-06 |
| 2025-03-31 | $324.97M 10-Q · filed 2026-08-06 |
| 2024-12-31 | $338.77M 10-Q · filed 2026-08-06 |
| 2024-09-30 | $366.98M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $406.16M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $438.00M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $464.81M 10-K · filed 2026-03-02 |
| 2023-09-30 | $424.34M 10-Q · filed 2024-10-31 |
| 2023-06-30 | $448.92M 10-Q · filed 2024-10-31 |
| 2023-03-31 | $473.54M 10-Q · filed 2024-10-31 |
| 2022-12-31 | $492.96M 10-K · filed 2026-03-02 |
| 2022-09-30 | $179.76M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $222.28M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $282.44M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $249.09M 10-K · filed 2025-03-05 |
| 2021-09-30 | $278.93M 10-Q · filed 2022-11-08 |
| 2021-06-30 | $321.47M 10-Q · filed 2022-11-08 |
| 2021-03-31 | $377.14M 10-Q · filed 2022-11-08 |
| 2020-12-31 | $409.92M 10-K · filed 2024-03-06 |
| 2019-12-31 | $245.68M 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |